Routine Transcervical Thymectomy in MEN-1 Patients

Sponsor
National University Health System, Singapore (Other)
Overall Status
Completed
CT.gov ID
NCT05061784
Collaborator
(none)
7
1
1.2
5.8

Study Details

Study Description

Brief Summary

A case series was built after review of available literature by searching four databases (PubMed, Embase, Medline and Cochrane Library) for observational studies or case reports on routine prophylactic TCT for MEN-1 and the development of thymic carcinoids.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Routine thymectomy, which has been performed

Detailed Description

Introduction and Importance Malignant thymic carcinoids are uncommon but important entities among patients with multiple endocrine neoplasia type 1 (MEN-1). Current treatment guidelines advise the performance of a routine transcervical thymectomy (TCT) during parathyroidectomy, to prevent its development, although data on the yield of this prophylactic TCT is scarce. We aimed to revisit available literature to investigate and summarize the efficacy of routine TCT during neck exploration for parathyroidectomy, for the prevention of thymic carcinoid tumours among MEN-1 patients.

Methods A case series was built after review of available literature by searching four databases (PubMed, Embase, Medline and Cochrane Library) for observational studies or case reports on routine prophylactic TCT for MEN-1 and the development of thymic carcinoids.

Study Design

Study Type:
Observational
Actual Enrollment :
7 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Revisiting the Evidence for Routine Transcervical Thymectomy for the Prevention of Thymic Carcinoid Tumours in MEN-1 Patients a Case Series
Actual Study Start Date :
Jul 14, 2021
Actual Primary Completion Date :
Aug 20, 2021
Actual Study Completion Date :
Aug 20, 2021

Arms and Interventions

Arm Intervention/Treatment
MEN-1 patients who underwent routine thymectomy during parathyroidecotmy

A case series was built after review of available literature by searching four databases (PubMed, Embase, Medline and Cochrane Library) for observational studies or case reports on routine prophylactic TCT for MEN-1 and the development of thymic carcinoids.

Procedure: Routine thymectomy, which has been performed
There is no intervention

Outcome Measures

Primary Outcome Measures

  1. Incidence of thyme carcinoid [The timeframe will be from date of transcervical thymectomy until the date of documented diagnosis of diagnosis of thymic NET; progression of disease or date of death from any cause, whichever came first, assessed up to 100 months.]

    Retrospective review of published studies

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Studies including MEN-1 patients who underwent a routine thymectomy during parathyoidectomy

  • We accepted randomized controlled trials or observational studies that included patients of any age who underwent a routine TCT in the setting for MEN-1, published as full-length articles in peer-reviewed journals, which mentioned data on thymic carcinoid tumours.

Exclusion Criteria:
  • We excluded reviews, letters, conference proceedings and non-English publications.

Contacts and Locations

Locations

Site City State Country Postal Code
1 National University Hospital Singapore Singapore

Sponsors and Collaborators

  • National University Health System, Singapore

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rajeev Parameswaran, Assistant Professor and Head & Senior Consultant, National University Health System, Singapore
ClinicalTrials.gov Identifier:
NCT05061784
Other Study ID Numbers:
  • exempt from review
First Posted:
Sep 30, 2021
Last Update Posted:
Sep 30, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Rajeev Parameswaran, Assistant Professor and Head & Senior Consultant, National University Health System, Singapore
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 30, 2021